Ms. Kelley Suzanne Lybrand is a Monroe, North Carolina based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 1851 Wellness Blvd, Monroe. Patients can reach her at 704-291-7333.
Ms. Kelley Suzanne Lybrand deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Ms. Kelley Suzanne Lybrand speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Ms. Kelley Suzanne Lybrand
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Female
Credentials:
D.D.S.
Accepts Medicare Assignment:
May Accept
Practice Address:
1851 Wellness Blvd, Monroe, North Carolina, 28110-7774
Phone:
704-291-7333
Fax:
704-292-1203
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
1759415664
Enrollment ID:
I20181206000089
NPI Number:
1265515399
NPI Enumeration Date:
23 Oct, 2006
NPI Last Update On:
15 Jan, 2020
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1851 Wellness Blvd, Monroe, North Carolina
Zip:
28110-7774
Phone Number:
704-291-7333
Fax Number:
704-292-1203
Patients can reach Ms. Kelley Suzanne Lybrand at 1851 Wellness Blvd, Monroe, North Carolina or can call to book an appointment on 704-291-7333. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.